524731
JENBURPH
Start SIP
Invest Now
Start SIP in JENBURPH
Performance
- Low
- ₹1,025
- High
- ₹1,065
- 52 Week Low
- ₹937
- 52 Week High
- ₹1,410
- Open Price₹1,027
- Previous Close₹1,042
- Volume777
- 50 DMA₹1,087.56
- 100 DMA₹1,110.19
- 200 DMA₹1,120.44
Investment Returns
- Over 1 Month -3.02%
- Over 3 Month -14.23%
- Over 6 Month -7.4%
- Over 1 Year -0.92%
Smart Investing Starts Here Start SIP with Jenburkt Pharmaceuticals for Steady Growth!
Jenburkt Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.4
- PEG Ratio
- 4.5
- Market Cap Cr
- 468
- P/B Ratio
- 2.6
- Average True Range
- 47.04
- EPS
- -
- Dividend Yield
- 1.7
- MACD Signal
- -10.56
- RSI
- 46.66
- MFI
- 23.75
Jenburkt Pharmaceuticals Financials
Jenburkt Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,060.00
+
17.7
(1.7%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹1,066.72
- 50 Day
- ₹1,087.56
- 100 Day
- ₹1,110.19
- 200 Day
- ₹1,120.44
Resistance and Support
1048.93
- R3 1,112.77
- R2 1,088.83
- R1 1,072.87
- S1 1,032.97
- S2 1,009.03
- S3 993.07
Jenburkt Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Jenburkt Pharmaceuticals F&O
About Jenburkt Pharmaceuticals
- NSE Symbol
- JENBURPH
- BSE Symbol
- 524731
- Chairman & Managing Director
- Mr. Ashish U Bhuta
- ISIN
- INE354A01013
Similar Stocks to Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals FAQs
Jenburkt Pharmaceuticals share price is ₹1,060 As on 13 February, 2026 | 23:24
The Market Cap of Jenburkt Pharmaceuticals is ₹467.8 Cr As on 13 February, 2026 | 23:24
The P/E ratio of Jenburkt Pharmaceuticals is 14.4 As on 13 February, 2026 | 23:24
The PB ratio of Jenburkt Pharmaceuticals is 2.6 As on 13 February, 2026 | 23:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.